---
title: Epidemiology and etiologies-atrial fibrillation
---
# Epidemiology and etiologies-atrial fibrillation


 (Circ A&E 2018;11:e006350)

* 1–2% of pop. has AF (10% of those age ≥80); M >F; lifetime risk ~25%; mean age 75 y

## Acute (up to 50% w/o identifiable cause)

* Cardiac:
	* HF, new CMP, myo/pericarditis, ischemia/MI, HTN crisis,
	* valve dis., cardiac surg
* Pulmonary:
	* acute pulmonary disease or hypoxemia (eg, COPD flare, PNA),
	* PE, OSA
* Metabolic:
	* high catecholamine states (stress, infection, postop, pheo),
	* thyrotoxicosis
* **Neurogenic**:
	* subarachnoid hemorrhage,
	* ischemic stroke
* Drugs:
	* alcohol, cocaine, amphetamines, smoking, ibrutinib

## Chronic:
* ↑ age, HTN, ischemia, valve dis. (MV, TV, AoV), CMP, hyperthyroidism, obesity
* Aggressive mgmt of HTN, OSA & EtOH (NEJM 2020;382:20) to ↓ risk

## Explain by ChatGPT


* AF can be asymptomatic or associated with fatigue, dyspnea, palpitations, or chest pain

Epidemiology and etiologies-atrial fibrillation

* 1–2% of the population has AF (10% of those age ≥80);
* Acute (up to 50% w/o identifiable cause)
* Cardiac: HF, new CMP, myo/pericarditis, ischemia/MI, HTN crisis, valve dis., cardiac surg
* Pulmonary: acute pulmonary disease or hypoxemia (eg, COPD flare, PNA), PE, OSA
* Metabolic: high catecholamine states (stress, infection, postop, pheo), thyrotoxicosis
* Drugs: alcohol, cocaine, amphetamines, smoking, ibrutinib
* Neurogenic: subarachnoid hemorrhage, ischemic stroke

* Chronic: ↑ age, HTN, ischemia, valve dis. (MV, TV, AoV), CMP, hyperthyroidism, obesity
* Aggressive mgmt of HTN, OSA & EtOH (NEJM 2020;382:20) to ↓ risk

* AF can be asymptomatic or associated with fatigue, dyspnea, palpitations, or chest pain

## 窩的英文不太好

* AF 可能沒有症狀或伴有疲勞、呼吸困難、心悸或胸痛

流行病學和病因學——房顫

* 1-2% 的人口患有房顫（其中 10% 的年齡≥80 歲）；
* 急性（高達 50% w/o 可識別原因）
* 心臟：心力衰竭、新 CMP、肌病/心包炎、缺血/心肌梗死、高血壓危象、瓣膜病、心臟外科手術
* 肺部：急性肺部疾病或低氧血症（例如，COPD 發作、PNA）、PE、OSA
* 代謝：高兒茶酚胺狀態（壓力、感染、術後、pheo）、甲狀腺毒症
* 藥物：酒精、可卡因、苯丙胺、吸煙、依魯替尼
* 神經源性：蛛網膜下腔出血、缺血性中風

* 慢性：↑ 年齡、高血壓、局部缺血、瓣膜病。 (MV, TV, AoV), CMP, 甲亢, 肥胖
* HTN、OSA 和 EtOH 的積極管理 (NEJM 2020;382:20) 到 ↓ 風險
* AF 可能沒有症狀或伴有疲勞、呼吸困難、心悸或胸痛
